Skip to main content

Peer Review reports

From: HSP90 inhibition sensitizes head and neck cancer to platin-based chemoradiotherapy by modulation of the DNA damage response resulting in chromosomal fragmentation

Original Submission
3 Aug 2016 Submitted Original manuscript
15 Oct 2016 Reviewed Reviewer Report - Tim Beck
21 Oct 2016 Reviewed Reviewer Report - Anna Gaponova
21 Dec 2016 Author responded Author comments - Martin McLaughlin
Resubmission - Version 2
21 Dec 2016 Submitted Manuscript version 2
23 Jan 2017 Editorially accepted
31 Jan 2017 Article published 10.1186/s12885-017-3084-0

You can find further information about peer review here.

Back to article page